3-Alkenyl-2-azetidinones as fatty acid amide hydrolase inhibitors.

Urbach, Allan;Muccioli, Giulio;Stern, Eric;Lambert, Didier;Marchand-Brynaert, Jacqueline
(2008) Bioorganic & Medicinal Chemistry Letters : the tetrahedron journal for research at the interface of chemistry and biology — Vol. 18, n° 14, p. 4163-4167 (2008)

Files

pdfdocument.pdf
  • Restricted Access
  • Adobe PDF
  • 268.23 KB

Details

Authors
  • Urbach, AllanUCLouvain
    Author
  • Author
  • Stern, EricUCLouvain
    Author
  • Author
  • Marchand-Brynaert, JacquelineUCLouvain
    Author
Abstract
A series of novel 2-azetidinones (beta-lactams) bearing short alkenyl chains at C3 and N1 have been prepared and evaluated in vitro as inhibitors of human FAAH. Compound 9c (1-(4'-pentenoyl-3-(4'-pentenyl)-2-azetidinone)) featured an IC(50) value of 4.5muM and a good selectivity for FAAH versus MGL.
Affiliations

Citations

Urbach, A., Muccioli, G., Stern, E., Lambert, D., & Marchand-Brynaert, J. (2008). 3-Alkenyl-2-azetidinones as fatty acid amide hydrolase inhibitors. Bioorganic & Medicinal Chemistry Letters : the tetrahedron journal for research at the interface of chemistry and biology, 18(14), 4163-4167. https://doi.org/10.1016/j.bmcl.2008.05.081 (Original work published 2008)